By Kate Gibson, MarketWatch

NEW YORK (MarketWatch) -- U.S. stocks climbed on Tuesday with sentiment bolstered by a round of corporate deals, including Toronto-Dominion Bank's $6.3 billion acquisition of Chrysler Financial.

The Dow Jones Industrial Average (DJI) gained 42.35 points, or 0.4%, to 11,520.48, with 24 of its 30 components on the rise.

The Dow "has made three attempts to close above 11,500 over the last 10 days and failed each time. That level appears to be a troublesome technical price resistance points that could prove stubborn to penetrate this week," noted Fred Dickson, chief investment strategist at Davidson Cos.

Rising for a fourth consecutive session, the Standard & Poor's 500 Index (SPX) climbed 5.36 points, or 0.4%, to 1,252.44. The financial sector proved the best performer among the index's 10 industry groups, while consumer staples lagged.

The Nasdaq Composite Index (RIXF) gained 12.63 points, or 0.5%, to 2,662.2.

On Monday, both the S&P 500 and Nasdaq notched new 2010 closing highs, levels that could keep funds from looking to hike their cash or take a more cautious stance ahead of the new year, analysts said.

"It's sort of a self-fulfilling prophecy. What can't take the market down will only make it stronger," said Marc Pado, U.S. market strategist at Cantor Fitzgerald.

For every issue that fell, two advanced on the New York Stock Exchange, where volume approached 197 million at 10:45 a.m. Eastern.

On Monday, NYSE volume was a mere 830 million shares, versus a 10-week average of 1.06 billion.

"Yesterday's volume might be an early warning that this year's seasonally slow week may be even more dramatic than anticipated," said Pado.

Adobe Systems Inc. (ADBE) gained after the graphic-software maker reported a profit that beat expectations. Jabil Circuit Inc. (JBL) also climbed after its outlook exceeded Wall Street projections.

"Tech has been a powerful leadership group, so this kind of positive forward-looking comment could help," offered Pado.

In addition to Toronto-Dominion Bank's (TD) agreement to acquire the lending arm of auto manufacturer Chrysler, Dutch chemicals company Royal DSM NV said it plans to purchase biotechnology firm Martek Biosciences Corp. (MATK) for $1.09 billion.

As Wall Street winds down the year, investors could view their dividend glass as either half full or half empty, depending on one's perspective.

Dividend income climbed 8.8% in 2010, and a 9% hike is likely in store in the year ahead, according to Howard Silverblatt, a senior index analyst at S&P Indices.

The less cheery news is that dividend payments remain 18.5% below where they stood in 2008, and it won't be until 2013 for dividends to return to those loftier levels, writes Silverblatt in a Tuesday research note.

 
 
Martek (NASDAQ:MATK)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Martek Charts.
Martek (NASDAQ:MATK)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Martek Charts.